Skip to main content
. Author manuscript; available in PMC: 2022 Feb 18.
Published in final edited form as: Pain. 2021 Jul 1;162(Suppl 1):S117–S124. doi: 10.1097/j.pain.0000000000002266

TABLE 5:

Research Priorities - Policy and societal issues

• Establish standards and regulations for testing cultivation and manufacturing quality, efficacy, and safety of cannabis products (similar to biopharmaceutics standards) before prescribing / marketing.
• Research marketing and advertising of cannabis products. Investigate consequences (use, effects) of banning benefit claims unsupported by robust data. Disallow advertising to children and adolescents.
• Investigate approaches to establish robust guidance for driving under cannabinoid influence.
• Establish education programs for vulnerable populations; leverage patient partners to improve outreach.
• Engage with clinicians and patient partners to establish education programs for healthcare providers to provide reliable information to patients, including in developing countries and countries where English is not the primary language.
• Investigate broader societal harms (e.g., addiction, psychosis, cognitive effects) in the context of pain management.
• Investigate approaches to incentivize or oblige the cannabis industry to fund high-quality cannabis research to support claims of efficacy, and for improving product quality and patient safety, while minimizing and managing conflict of interest.